Oral Thin Film Drugs-Europe Market Status and Trend Report 2013-2023
Report Summary
Oral Thin Film Drugs-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Thin Film Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oral Thin Film Drugs 2013-2017, and development forecast 2018-2023
Main market players of Oral Thin Film Drugs in Europe, with company and product introduction, position in the Oral Thin Film Drugs market
Market status and development trend of Oral Thin Film Drugs by types and applications
Cost and profit status of Oral Thin Film Drugs, and marketing status
Market growth drivers and challenges
The report segments the Europe Oral Thin Film Drugs market as:
Europe Oral Thin Film Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oral Thin Film Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sublingual Film
Fully Dissolving Dental/Buccal Film
Europe Oral Thin Film Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Europe Oral Thin Film Drugs Market: Players Segment Analysis (Company and Product introduction, Oral Thin Film Drugs Sales Volume, Revenue, Price and Gross Margin):
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer, Inc.
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Thin Film Drugs-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Thin Film Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Oral Thin Film Drugs 2013-2017, and development forecast 2018-2023
Main market players of Oral Thin Film Drugs in Europe, with company and product introduction, position in the Oral Thin Film Drugs market
Market status and development trend of Oral Thin Film Drugs by types and applications
Cost and profit status of Oral Thin Film Drugs, and marketing status
Market growth drivers and challenges
The report segments the Europe Oral Thin Film Drugs market as:
Europe Oral Thin Film Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Oral Thin Film Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Sublingual Film
Fully Dissolving Dental/Buccal Film
Europe Oral Thin Film Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Schizophrenia
Migraine
Opioid Dependence
Nausea & Vomiting
Others
Europe Oral Thin Film Drugs Market: Players Segment Analysis (Company and Product introduction, Oral Thin Film Drugs Sales Volume, Revenue, Price and Gross Margin):
Sumitomo Dainippon Pharma Co., Ltd.
Pfizer, Inc.
Novartis AG
ZIM Laboratories Limited
Indivior Plc.
Allergan Plc.
IntelGenx Corp
NAL Pharma
Wolters Kluwer
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL THIN FILM DRUGS
1.1 Definition of Oral Thin Film Drugs in This Report
1.2 Commercial Types of Oral Thin Film Drugs
1.2.1 Sublingual Film
1.2.2 Fully Dissolving Dental/Buccal Film
1.3 Downstream Application of Oral Thin Film Drugs
1.3.1 Schizophrenia
1.3.2 Migraine
1.3.3 Opioid Dependence
1.3.4 Nausea & Vomiting
1.3.5 Others
1.4 Development History of Oral Thin Film Drugs
1.5 Market Status and Trend of Oral Thin Film Drugs 2013-2023
1.5.1 EMEA Oral Thin Film Drugs Market Status and Trend 2013-2023
1.5.2 Regional Oral Thin Film Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Thin Film Drugs in EMEA 2013-2017
2.2 Consumption Market of Oral Thin Film Drugs in EMEA by Regions
2.2.1 Consumption Volume of Oral Thin Film Drugs in EMEA by Regions
2.2.2 Revenue of Oral Thin Film Drugs in EMEA by Regions
2.3 Market Analysis of Oral Thin Film Drugs in EMEA by Regions
2.3.1 Market Analysis of Oral Thin Film Drugs in Europe 2013-2017
2.3.2 Market Analysis of Oral Thin Film Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Oral Thin Film Drugs in Africa 2013-2017
2.4 Market Development Forecast of Oral Thin Film Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Oral Thin Film Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Oral Thin Film Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Oral Thin Film Drugs in EMEA by Types
3.1.2 Revenue of Oral Thin Film Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Oral Thin Film Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Thin Film Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Africa
4.3 Market Forecast of Oral Thin Film Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL THIN FILM DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Oral Thin Film Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL THIN FILM DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Oral Thin Film Drugs in EMEA by Major Players
6.2 Revenue of Oral Thin Film Drugs in EMEA by Major Players
6.3 Basic Information of Oral Thin Film Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Oral Thin Film Drugs Major Players
6.3.2 Employees and Revenue Level of Oral Thin Film Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL THIN FILM DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sumitomo Dainippon Pharma Co., Ltd.
7.1.1 Company profile
7.1.2 Representative Oral Thin Film Drugs Product
7.1.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Sumitomo Dainippon Pharma Co., Ltd.
7.2 Pfizer, Inc.
7.2.1 Company profile
7.2.2 Representative Oral Thin Film Drugs Product
7.2.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.3 Novartis AG
7.3.1 Company profile
7.3.2 Representative Oral Thin Film Drugs Product
7.3.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Novartis AG
7.4 ZIM Laboratories Limited
7.4.1 Company profile
7.4.2 Representative Oral Thin Film Drugs Product
7.4.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of ZIM Laboratories Limited
7.5 Indivior Plc.
7.5.1 Company profile
7.5.2 Representative Oral Thin Film Drugs Product
7.5.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Indivior Plc.
7.6 Allergan Plc.
7.6.1 Company profile
7.6.2 Representative Oral Thin Film Drugs Product
7.6.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Allergan Plc.
7.7 IntelGenx Corp
7.7.1 Company profile
7.7.2 Representative Oral Thin Film Drugs Product
7.7.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of IntelGenx Corp
7.8 NAL Pharma
7.8.1 Company profile
7.8.2 Representative Oral Thin Film Drugs Product
7.8.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of NAL Pharma
7.9 Wolters Kluwer
7.9.1 Company profile
7.9.2 Representative Oral Thin Film Drugs Product
7.9.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Wolters Kluwer
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL THIN FILM DRUGS
8.1 Industry Chain of Oral Thin Film Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL THIN FILM DRUGS
9.1 Cost Structure Analysis of Oral Thin Film Drugs
9.2 Raw Materials Cost Analysis of Oral Thin Film Drugs
9.3 Labor Cost Analysis of Oral Thin Film Drugs
9.4 Manufacturing Expenses Analysis of Oral Thin Film Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL THIN FILM DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oral Thin Film Drugs in This Report
1.2 Commercial Types of Oral Thin Film Drugs
1.2.1 Sublingual Film
1.2.2 Fully Dissolving Dental/Buccal Film
1.3 Downstream Application of Oral Thin Film Drugs
1.3.1 Schizophrenia
1.3.2 Migraine
1.3.3 Opioid Dependence
1.3.4 Nausea & Vomiting
1.3.5 Others
1.4 Development History of Oral Thin Film Drugs
1.5 Market Status and Trend of Oral Thin Film Drugs 2013-2023
1.5.1 EMEA Oral Thin Film Drugs Market Status and Trend 2013-2023
1.5.2 Regional Oral Thin Film Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Thin Film Drugs in EMEA 2013-2017
2.2 Consumption Market of Oral Thin Film Drugs in EMEA by Regions
2.2.1 Consumption Volume of Oral Thin Film Drugs in EMEA by Regions
2.2.2 Revenue of Oral Thin Film Drugs in EMEA by Regions
2.3 Market Analysis of Oral Thin Film Drugs in EMEA by Regions
2.3.1 Market Analysis of Oral Thin Film Drugs in Europe 2013-2017
2.3.2 Market Analysis of Oral Thin Film Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Oral Thin Film Drugs in Africa 2013-2017
2.4 Market Development Forecast of Oral Thin Film Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Oral Thin Film Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Oral Thin Film Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Oral Thin Film Drugs in EMEA by Types
3.1.2 Revenue of Oral Thin Film Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Oral Thin Film Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Thin Film Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Oral Thin Film Drugs by Downstream Industry in Africa
4.3 Market Forecast of Oral Thin Film Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL THIN FILM DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Oral Thin Film Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL THIN FILM DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Oral Thin Film Drugs in EMEA by Major Players
6.2 Revenue of Oral Thin Film Drugs in EMEA by Major Players
6.3 Basic Information of Oral Thin Film Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Oral Thin Film Drugs Major Players
6.3.2 Employees and Revenue Level of Oral Thin Film Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL THIN FILM DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sumitomo Dainippon Pharma Co., Ltd.
7.1.1 Company profile
7.1.2 Representative Oral Thin Film Drugs Product
7.1.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Sumitomo Dainippon Pharma Co., Ltd.
7.2 Pfizer, Inc.
7.2.1 Company profile
7.2.2 Representative Oral Thin Film Drugs Product
7.2.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.3 Novartis AG
7.3.1 Company profile
7.3.2 Representative Oral Thin Film Drugs Product
7.3.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Novartis AG
7.4 ZIM Laboratories Limited
7.4.1 Company profile
7.4.2 Representative Oral Thin Film Drugs Product
7.4.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of ZIM Laboratories Limited
7.5 Indivior Plc.
7.5.1 Company profile
7.5.2 Representative Oral Thin Film Drugs Product
7.5.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Indivior Plc.
7.6 Allergan Plc.
7.6.1 Company profile
7.6.2 Representative Oral Thin Film Drugs Product
7.6.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Allergan Plc.
7.7 IntelGenx Corp
7.7.1 Company profile
7.7.2 Representative Oral Thin Film Drugs Product
7.7.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of IntelGenx Corp
7.8 NAL Pharma
7.8.1 Company profile
7.8.2 Representative Oral Thin Film Drugs Product
7.8.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of NAL Pharma
7.9 Wolters Kluwer
7.9.1 Company profile
7.9.2 Representative Oral Thin Film Drugs Product
7.9.3 Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin of Wolters Kluwer
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL THIN FILM DRUGS
8.1 Industry Chain of Oral Thin Film Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL THIN FILM DRUGS
9.1 Cost Structure Analysis of Oral Thin Film Drugs
9.2 Raw Materials Cost Analysis of Oral Thin Film Drugs
9.3 Labor Cost Analysis of Oral Thin Film Drugs
9.4 Manufacturing Expenses Analysis of Oral Thin Film Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL THIN FILM DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
